Incresync
Active substance: alogliptin, pioglitazone
alogliptin, pioglitazone
Centralised EU authorisationActive
Marketing holder: Takeda Pharma A/S
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
- alogliptin
- pioglitazone
Registration
- Registration number
- EMEA/H/C/002178
- Registration status
- Active
- ATC code
- A10BD09
Sources
- product · EMA · EMEA/H/C/002178 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002178 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002178 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/002178 · Verified 2026-10-09